 |
The Journal of Neuroscience, November 1, 2006, 26(44):11295-11303; doi:10.1523/JNEUROSCI.1794-06.2006
Previous Article | Next Article 
Cellular/Molecular
An Acute Effect of Neuregulin 1 to Suppress 7-Containing Nicotinic Acetylcholine Receptors in Hippocampal Interneurons
Qing Chang and
Gerald D. Fischbach
Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032
Correspondence should be addressed to Dr. Gerald D. Fischbach, Department of Pharmacology, Columbia University, 630 West 168th Street, New York, NY 10032. Email: gdf{at}columbia.edux
We examined rapid effects of neuregulin (NRG) on nicotinic acetylcholine (ACh) receptors in interneurons located in the stratum radiatum of the hippocampus. Two types of response were detected by whole-cell recordings after brief pulses of ACh. One type was a rapidly rising and falling (monophasic) current that was blocked by methyllycaconitine. The other type was a similar fast response followed by a more slowly rising and falling current. The slow component of the biphasic response was resistant to methyllycaconitine. Perfusion or local application with NRG 1 rapidly decreased fast inward ACh currents. NRG 1 had no effect on slow responses. NRG 1 suppression was abolished by the ErbB tyrosine kinase inhibitor PD 158780 (4-[(3-bromophenyl) amino]-6-(methylamino)-pyrido[3,4-d]pyridimine). The NRG 1 effect was also inhibited by phalloidin and cytochalasin D. Furthermore, NRG 1 decreased the number of surface Alexa Fluor 488 -bungarotoxin binding sites. We believe that the NRG 1 -induced inhibition of ACh currents is because of receptor internalization trigged by protein tyrosine phosphorylation. Significantly, fast nicotinic EPSCs evoked in the presence of muscarinic, ionotropic glutamate, and GABA receptors antagonists were also reduced by NRG 1 . Thus, short-term as well as long-term effects of NRG must be taken into consideration in studies of ACh receptor-mediated synaptic efficacy in the CNS.
Key words: neuregulin; ErbB receptor; nicotinic acetylcholine receptor; hippocampus; interneurons; synaptic transmission
Received April 27, 2006;
revised Sept. 15, 2006;
accepted Sept. 15, 2006.
Correspondence should be addressed to Dr. Gerald D. Fischbach, Department of Pharmacology, Columbia University, 630 West 168th Street, New York, NY 10032. Email: gdf{at}columbia.edux
This article has been cited by other articles:

|
 |

|
 |
 
T. Dejaegere, L. Serneels, M. K. Schafer, J. Van Biervliet, K. Horre, C. Depboylu, D. Alvarez-Fischer, A. Herreman, M. Willem, C. Haass, et al.
Deficiency of Aph1B/C-{gamma}-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment
PNAS,
July 15, 2008;
105(28):
9775 - 9780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Fernandes, A. Pinto-Duarte, J. A. Ribeiro, and A. M. Sebastiao
Postsynaptic Action of Brain-Derived Neurotrophic Factor Attenuates {alpha}7 Nicotinic Acetylcholine Receptor-Mediated Responses in Hippocampal Interneurons
J. Neurosci.,
May 21, 2008;
28(21):
5611 - 5618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Hancock, S. E. Canetta, L. W. Role, and D. A. Talmage
Presynaptic Type III Neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons
J. Cell Biol.,
May 1, 2008;
181(3):
511 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Mathew, A. J. Law, B. K. Lipska, M. I. Davila-Garcia, E. D. Zamora, S. N. Mitkus, R. Vakkalanka, R. E. Straub, D. R. Weinberger, J. E. Kleinman, et al.
{alpha}7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1
Hum. Mol. Genet.,
December 1, 2007;
16(23):
2921 - 2932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang and D. K. Berg
Reversible inhibition of GABAA receptors by {alpha}7-containing nicotinic receptors on the vertebrate postsynaptic neurons
J. Physiol.,
March 15, 2007;
579(3):
753 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|